Is Qualigen Therapeutics, Inc. (QLGN) a Buy, Sell, or Hold?
NASDAQ : QLGN
Qualigen Therapeutics, Inc. — Competitors
$3.21 USD
$0.17 (5.59%)
- Volume
- 368.77K
- Average Volume
- 2.65M
- Market Capitalization
- $5.43M
- P/E Ratio
- -0.51
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $8.81
- Year Low
- $1.61
- Day High
- —
- Day Low
- —
- Payout Ratio
- -$0.07
- Current Ratio
- $3.68
QLGN vs. The Competition
| Properties | QLGN | CANF | CMND | CNSP |
|---|---|---|---|---|
| Market Cap | $5.43M | $4.5M | $2.42M | $7.86M |
| Shares Outstanding | $1.69M | $1.31M | $1.49M | $1.46M |
| P/E Ratio | -0.51 | -0.77 | -0.14 | -0.18 |
| EPS | -1.26 | -9.12 | -26.17 | -24.38 |
| Day Low | 2.86 | 3.4 | 1.58 | 5.19 |
| Day High | 3.3358 | 3.4904 | 1.75 | 5.38 |
| Year Low | 1.61 | 2.56 | 1.43 | 1.9 |
| Year High | 8.81 | 14 | 524 | 10.588 |
| Average Price 50 | 3.6306 | 3.2116 | 2.3894 | 4.96668 |
| Average Price 200 | 3.20449 | 4.40825 | 43.14655 | 5.00395 |
| Volume | 368.77K | 28715 | 79149 | 1973 |
| Average Volume | - | - | - | - |